fig1

Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing

Figure 1. Mechanism of action of ADCs. ADCs bind to target antigens on cancer cells, forming an ADC-antigen complex, which is internalized via endocytosis[5]. Within endosomes, cleavable linkers release the cytotoxic payload upon fusion with lysosomes, triggering mechanisms like DNA intercalation and microtubule disruption that lead to apoptosis. Additionally, the bystander effect allows the cytotoxic payload to impact neighboring tumor cells, enhancing therapeutic efficacy. Created in BioRender. Larose, E. (2024) https://BioRender.com/f12z842. ADCs: Antibody-drug conjugates.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/